Directorate changes

RNS Number : 9505W
Chemring Group PLC
16 December 2019
 

FOR IMMEDIATE RELEASE                                                                             16 DECEMBER 2019

 

 

CHEMRING GROUP PLC ("Chemring" or the "Company")

 DIRECTORATE CHANGES

Chemring today announces the following directorate changes.

 

Nigel Young, who has served as a non-executive director for nearly seven years, has indicated his intention to retire on 30 April 2020, when his current appointment comes to an end.

 

Andrew Davies, Chairman of Chemring's Remuneration Committee, will be stepping down as Chairman of the Remuneration Committee following the Company's Annual General Meeting in March 2020 and will be succeeded by Laurie Bowen. Andrew Davies will remain a member of the Remuneration Committee.

 

 

-ENDS-

 

For further information:

 

Rupert Pittman            Group Director of Corporate Affairs,                        01794 833901

Chemring Group PLC              

Andrew Jaques            MHP Communications                                                020 3128 8100

Oliver Hughes           

 

 

Notes to editors

 

·  Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

·   Employing approximately 2,500 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is now organised under two strategic product segments: Sensors & Information and Countermeasures &  Energetics

·   Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

·   Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAGMMMZVVVGLZG
UK 100

Latest directors dealings